Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BioAtla (BCAB) Free Cash Flow (2020 - 2025)

BioAtla (BCAB) has disclosed Free Cash Flow for 6 consecutive years, with -$7.9 million as the latest value for Q4 2025.

  • For Q4 2025, Free Cash Flow rose 52.84% year-over-year to -$7.9 million; the TTM value through Dec 2025 reached -$48.2 million, up 32.99%, while the annual FY2025 figure was -$48.2 million, 32.99% up from the prior year.
  • Free Cash Flow hit -$7.9 million in Q4 2025 for BioAtla, up from -$9.9 million in the prior quarter.
  • Across five years, Free Cash Flow topped out at -$5.1 million in Q3 2024 and bottomed at -$30.8 million in Q1 2024.
  • Average Free Cash Flow over 5 years is -$18.9 million, with a median of -$18.1 million recorded in 2022.
  • Year-over-year, Free Cash Flow tumbled 376.27% in 2021 and then surged 81.25% in 2024.
  • BioAtla's Free Cash Flow stood at -$20.9 million in 2021, then dropped by 16.41% to -$24.4 million in 2022, then decreased by 22.77% to -$29.9 million in 2023, then soared by 43.93% to -$16.8 million in 2024, then soared by 52.84% to -$7.9 million in 2025.
  • According to Business Quant data, Free Cash Flow over the past three periods came in at -$7.9 million, -$9.9 million, and -$14.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.